It is our pleasure to announce that the 2022 edition of the European Delirium Association (EDA) annual meeting will be held in Monza, Italy, on 2-4 November 2022. Monza is a medium-sized city very close to Milan, which is famous for many attractions, including its magnificent Cathedral, the Autodrome race track and the Royal park, which extends over an area of 700 hectares. The conference will be held in person. However, in the event of a new pandemic wave, the meeting will move to a virtual format.

Since its first edition, the EDA annual meeting has progressively become a crucial event for all researchers and healthcare professionals interested in delirium. Previous editions have attracted researchers, clinicians, and other healthcare professionals from across the world, including Europe, North America, Australia, South America and Asia, and we believe that this global attendance will increase further with the upcoming edition.

The EDA meeting will cover several aspects related to delirium. On the opening day, we will talk about delirium and the legacy of the COVID-19 pandemic, providing interesting insights for clinicians and healthcare professionals who are involved in the care of patients with delirium. The Conference programme will also feature sessions on delirium pathophysiology, on the pediatric diagnosis and management of delirium, on the risk factors for post-surgical delirium, on multimodal pre-habilitation to prevent delirium, and on the diagnosis of delirium across various settings of care (emergency department, acute surgical and medical wards, rehabilitation, palliative care and hospice, nursing home and long-term care). There will also be a dedicated session focusing on the management of pain, sleep, and sedation in Intensive Care Units (ICUs), on the use of virtual reality to cope with post-ICU delirium problems, and on the optimisation of the ICU environment to prevent delirium. Another session of the meeting will specifically focus on the use of artificial intelligence to help delirium researchers and clinicians in their everyday activity, as well as a session to address the challenges and opportunities of teaching about delirium in medical schools.

The 2022 meeting will also host a joint symposium organised by the EDA and the European Union of the Geriatric Medicine Societies (EuGMS), which will focus on the prevention of delirium using melatoninergic drugs and orexin inhibitors, as well on the relationship between medications and delirium, and on the surgical prevention of delirium. The meeting will be supported by the Italian Society of Geriatrics and Gerontologists (SIGG), the Italian Association of Psychogeriatrics (AIP), the Italian Association of Intensivists and Anesthesiologists (SIAARTI).

A pre-conference event will be hosted on November 2nd in the Italian language: it will be a teaching day for local healthcare providers aiming to improve their current knowledge on delirium.

We believe that the 2022 Conference will be a breakthrough event in increasing awareness and biological understanding of this very prevalent syndrome. Delirium still affects 1 out of 5 hospitalised patients and, therefore, represents a significant priority not only for the patients, who are affected, but also for hospitals, long-term care settings and all areas of the National health systems.

In the coming weeks, you will receive the preliminary programme and all the necessary information on the upcoming Conference.

The Local Organizing Committee
Prof. Giuseppe Bellelli, Prof. Giuseppe Citerio, Dr. Alessandro Morandi
The EDA president
Arjen Slooter